NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announced a one-time special cash dividend of $0.80 per share of common stock, payable to stockholders of record as part of the Company's capital return strategy following its strategic restructuring and asset monetization program.
The dividend reflects the Company's progress in strengthening its balance sheet and returning value to shareholders as it continues to evaluate strategic alternatives under the leadership of David Lazar.